CN101117625A - 诱导间充质干细胞和脂肪干细胞分化为神经元的方法及其专用培养基 - Google Patents
诱导间充质干细胞和脂肪干细胞分化为神经元的方法及其专用培养基 Download PDFInfo
- Publication number
- CN101117625A CN101117625A CNA2007101187265A CN200710118726A CN101117625A CN 101117625 A CN101117625 A CN 101117625A CN A2007101187265 A CNA2007101187265 A CN A2007101187265A CN 200710118726 A CN200710118726 A CN 200710118726A CN 101117625 A CN101117625 A CN 101117625A
- Authority
- CN
- China
- Prior art keywords
- stem cell
- sequence
- cell
- neuron
- slow virus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 210000000130 stem cell Anatomy 0.000 title claims abstract description 70
- 238000000034 method Methods 0.000 title claims abstract description 47
- 239000001963 growth medium Substances 0.000 title abstract description 12
- 210000002569 neuron Anatomy 0.000 title abstract description 10
- 230000004069 differentiation Effects 0.000 title description 15
- 230000000763 evoking effect Effects 0.000 title 1
- 210000003716 mesoderm Anatomy 0.000 title 1
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 51
- 210000002901 mesenchymal stem cell Anatomy 0.000 claims abstract description 21
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 claims abstract description 19
- 230000001939 inductive effect Effects 0.000 claims abstract description 19
- 210000002966 serum Anatomy 0.000 claims abstract description 15
- 210000004027 cell Anatomy 0.000 claims description 78
- 102100022940 RE1-silencing transcription factor Human genes 0.000 claims description 64
- 241000700605 Viruses Species 0.000 claims description 61
- 239000013598 vector Substances 0.000 claims description 60
- 230000014509 gene expression Effects 0.000 claims description 52
- 108010049420 RE1-silencing transcription factor Proteins 0.000 claims description 38
- 108020004459 Small interfering RNA Proteins 0.000 claims description 34
- 238000001890 transfection Methods 0.000 claims description 29
- 230000002068 genetic effect Effects 0.000 claims description 15
- 239000013612 plasmid Substances 0.000 claims description 15
- 108091032973 (ribonucleotides)n+m Proteins 0.000 claims description 13
- 244000309466 calf Species 0.000 claims description 12
- 238000006243 chemical reaction Methods 0.000 claims description 12
- 230000000692 anti-sense effect Effects 0.000 claims description 11
- 239000002773 nucleotide Substances 0.000 claims description 11
- 125000003729 nucleotide group Chemical group 0.000 claims description 11
- 238000012856 packing Methods 0.000 claims description 11
- 230000005764 inhibitory process Effects 0.000 claims description 9
- 244000025254 Cannabis sativa Species 0.000 claims description 7
- 230000003321 amplification Effects 0.000 claims description 7
- 238000003199 nucleic acid amplification method Methods 0.000 claims description 7
- 238000004806 packaging method and process Methods 0.000 claims description 7
- 102000040650 (ribonucleotides)n+m Human genes 0.000 claims description 6
- 101710091045 Envelope protein Proteins 0.000 claims description 6
- 101710188315 Protein X Proteins 0.000 claims description 6
- 102100021696 Syncytin-1 Human genes 0.000 claims description 6
- 210000003692 ilium Anatomy 0.000 claims description 6
- 108091028043 Nucleic acid sequence Proteins 0.000 claims description 5
- 238000000338 in vitro Methods 0.000 claims description 5
- NWXMGUDVXFXRIG-WESIUVDSSA-N (4s,4as,5as,6s,12ar)-4-(dimethylamino)-1,6,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboxamide Chemical compound C1=CC=C2[C@](O)(C)[C@H]3C[C@H]4[C@H](N(C)C)C(=O)C(C(N)=O)=C(O)[C@@]4(O)C(=O)C3=C(O)C2=C1O NWXMGUDVXFXRIG-WESIUVDSSA-N 0.000 claims description 4
- 238000009396 hybridization Methods 0.000 claims description 4
- 101100352418 Caenorhabditis elegans plp-1 gene Proteins 0.000 claims description 3
- 239000002502 liposome Substances 0.000 claims description 3
- 238000012364 cultivation method Methods 0.000 claims description 2
- 210000004700 fetal blood Anatomy 0.000 claims description 2
- 210000002826 placenta Anatomy 0.000 claims description 2
- 230000008521 reorganization Effects 0.000 claims description 2
- 241000701161 unidentified adenovirus Species 0.000 claims description 2
- 101000911390 Homo sapiens Coagulation factor VIII Proteins 0.000 claims 1
- 238000010276 construction Methods 0.000 claims 1
- 102000057593 human F8 Human genes 0.000 claims 1
- 229940047431 recombinate Drugs 0.000 claims 1
- 230000000452 restraining effect Effects 0.000 abstract 2
- 241000283690 Bos taurus Species 0.000 abstract 1
- 210000003754 fetus Anatomy 0.000 abstract 1
- 101000756346 Homo sapiens RE1-silencing transcription factor Proteins 0.000 description 47
- 210000004271 bone marrow stromal cell Anatomy 0.000 description 15
- 108020004999 messenger RNA Proteins 0.000 description 11
- 238000001514 detection method Methods 0.000 description 10
- 230000000694 effects Effects 0.000 description 10
- 239000007788 liquid Substances 0.000 description 10
- 239000000047 product Substances 0.000 description 9
- 230000029087 digestion Effects 0.000 description 8
- 238000002156 mixing Methods 0.000 description 8
- 238000003757 reverse transcription PCR Methods 0.000 description 8
- 239000000243 solution Substances 0.000 description 8
- 108020004414 DNA Proteins 0.000 description 7
- 239000000203 mixture Substances 0.000 description 7
- 235000015097 nutrients Nutrition 0.000 description 7
- 230000008859 change Effects 0.000 description 5
- 238000013461 design Methods 0.000 description 5
- 201000010099 disease Diseases 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 230000009368 gene silencing by RNA Effects 0.000 description 5
- 238000011532 immunohistochemical staining Methods 0.000 description 5
- 208000015181 infectious disease Diseases 0.000 description 5
- 239000006228 supernatant Substances 0.000 description 5
- 230000003612 virological effect Effects 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- 238000001262 western blot Methods 0.000 description 5
- 244000050510 Cunninghamia lanceolata Species 0.000 description 4
- 102000004190 Enzymes Human genes 0.000 description 4
- 108090000790 Enzymes Proteins 0.000 description 4
- 102100039289 Glial fibrillary acidic protein Human genes 0.000 description 4
- 101710193519 Glial fibrillary acidic protein Proteins 0.000 description 4
- 229920000209 Hexadimethrine bromide Polymers 0.000 description 4
- 239000012097 Lipofectamine 2000 Substances 0.000 description 4
- 102100038550 Neurogenin-1 Human genes 0.000 description 4
- 101710096136 Neurogenin-1 Proteins 0.000 description 4
- 102000004874 Synaptophysin Human genes 0.000 description 4
- 108090001076 Synaptophysin Proteins 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 229940088598 enzyme Drugs 0.000 description 4
- 238000011156 evaluation Methods 0.000 description 4
- 239000000284 extract Substances 0.000 description 4
- 239000012530 fluid Substances 0.000 description 4
- 210000005046 glial fibrillary acidic protein Anatomy 0.000 description 4
- 230000003834 intracellular effect Effects 0.000 description 4
- 230000001537 neural effect Effects 0.000 description 4
- 230000003961 neuronal insult Effects 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 3
- 238000012228 RNA interference-mediated gene silencing Methods 0.000 description 3
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 3
- 230000001413 cellular effect Effects 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- 238000012258 culturing Methods 0.000 description 3
- 238000013016 damping Methods 0.000 description 3
- 238000004043 dyeing Methods 0.000 description 3
- 239000003797 essential amino acid Substances 0.000 description 3
- 210000003811 finger Anatomy 0.000 description 3
- 238000012151 immunohistochemical method Methods 0.000 description 3
- 210000005036 nerve Anatomy 0.000 description 3
- 238000001556 precipitation Methods 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 238000003753 real-time PCR Methods 0.000 description 3
- 238000010839 reverse transcription Methods 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 238000012546 transfer Methods 0.000 description 3
- 239000011701 zinc Substances 0.000 description 3
- 229910052725 zinc Inorganic materials 0.000 description 3
- 108010085238 Actins Proteins 0.000 description 2
- 208000024827 Alzheimer disease Diseases 0.000 description 2
- 201000006474 Brain Ischemia Diseases 0.000 description 2
- 102000004219 Brain-derived neurotrophic factor Human genes 0.000 description 2
- 108090000715 Brain-derived neurotrophic factor Proteins 0.000 description 2
- 102000029816 Collagenase Human genes 0.000 description 2
- 108060005980 Collagenase Proteins 0.000 description 2
- 108010043121 Green Fluorescent Proteins Proteins 0.000 description 2
- 102000004144 Green Fluorescent Proteins Human genes 0.000 description 2
- 241000282414 Homo sapiens Species 0.000 description 2
- 101000697510 Homo sapiens Stathmin-2 Proteins 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- -1 NF-200 Proteins 0.000 description 2
- 102000008730 Nestin Human genes 0.000 description 2
- 108010088225 Nestin Proteins 0.000 description 2
- 239000012124 Opti-MEM Substances 0.000 description 2
- 241000283973 Oryctolagus cuniculus Species 0.000 description 2
- 238000012408 PCR amplification Methods 0.000 description 2
- 208000018737 Parkinson disease Diseases 0.000 description 2
- 108091030071 RNAI Proteins 0.000 description 2
- 108091027548 SiDNA Proteins 0.000 description 2
- 102100028051 Stathmin-2 Human genes 0.000 description 2
- 239000006180 TBST buffer Substances 0.000 description 2
- 108700019146 Transgenes Proteins 0.000 description 2
- 102000004243 Tubulin Human genes 0.000 description 2
- 108090000704 Tubulin Proteins 0.000 description 2
- 210000000577 adipose tissue Anatomy 0.000 description 2
- 238000000246 agarose gel electrophoresis Methods 0.000 description 2
- 208000036815 beta tubulin Diseases 0.000 description 2
- 230000003115 biocidal effect Effects 0.000 description 2
- 238000004113 cell culture Methods 0.000 description 2
- 239000006285 cell suspension Substances 0.000 description 2
- 229960002424 collagenase Drugs 0.000 description 2
- 239000002299 complementary DNA Substances 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 108010048367 enhanced green fluorescent protein Proteins 0.000 description 2
- 235000020776 essential amino acid Nutrition 0.000 description 2
- 239000012634 fragment Substances 0.000 description 2
- 239000005090 green fluorescent protein Substances 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 238000011081 inoculation Methods 0.000 description 2
- 230000002452 interceptive effect Effects 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 238000010369 molecular cloning Methods 0.000 description 2
- 210000005055 nestin Anatomy 0.000 description 2
- 230000026731 phosphorylation Effects 0.000 description 2
- 238000006366 phosphorylation reaction Methods 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 108091008146 restriction endonucleases Proteins 0.000 description 2
- 239000011435 rock Substances 0.000 description 2
- 229920006395 saturated elastomer Polymers 0.000 description 2
- 238000007789 sealing Methods 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 230000003584 silencer Effects 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 2
- 230000002103 transcriptional effect Effects 0.000 description 2
- 230000009385 viral infection Effects 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 1
- 102000000584 Calmodulin Human genes 0.000 description 1
- 108010041952 Calmodulin Proteins 0.000 description 1
- 241000283707 Capra Species 0.000 description 1
- 206010008120 Cerebral ischaemia Diseases 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 102000053602 DNA Human genes 0.000 description 1
- 102000012410 DNA Ligases Human genes 0.000 description 1
- 108010061982 DNA Ligases Proteins 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 241000620209 Escherichia coli DH5[alpha] Species 0.000 description 1
- 230000005526 G1 to G0 transition Effects 0.000 description 1
- 108010001336 Horseradish Peroxidase Proteins 0.000 description 1
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
- 241000713666 Lentivirus Species 0.000 description 1
- 102000003960 Ligases Human genes 0.000 description 1
- 108090000364 Ligases Proteins 0.000 description 1
- XUYPXLNMDZIRQH-LURJTMIESA-N N-acetyl-L-methionine Chemical compound CSCC[C@@H](C(O)=O)NC(C)=O XUYPXLNMDZIRQH-LURJTMIESA-N 0.000 description 1
- 102000008763 Neurofilament Proteins Human genes 0.000 description 1
- 108010088373 Neurofilament Proteins Proteins 0.000 description 1
- 108091034117 Oligonucleotide Proteins 0.000 description 1
- 108010019160 Pancreatin Proteins 0.000 description 1
- 229930040373 Paraformaldehyde Natural products 0.000 description 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
- 108091081021 Sense strand Proteins 0.000 description 1
- 108091027967 Small hairpin RNA Proteins 0.000 description 1
- 108010043943 Starch Phosphorylase Proteins 0.000 description 1
- 101710172711 Structural protein Proteins 0.000 description 1
- 208000037065 Subacute sclerosing leukoencephalitis Diseases 0.000 description 1
- 206010042297 Subacute sclerosing panencephalitis Diseases 0.000 description 1
- 108700009124 Transcription Initiation Site Proteins 0.000 description 1
- 108091023040 Transcription factor Proteins 0.000 description 1
- 102000040945 Transcription factor Human genes 0.000 description 1
- 102000004142 Trypsin Human genes 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- 108091000117 Tyrosine 3-Monooxygenase Proteins 0.000 description 1
- 102000048218 Tyrosine 3-monooxygenases Human genes 0.000 description 1
- 108010003533 Viral Envelope Proteins Proteins 0.000 description 1
- 101710185494 Zinc finger protein Proteins 0.000 description 1
- 102100023597 Zinc finger protein 816 Human genes 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 238000000137 annealing Methods 0.000 description 1
- 230000002457 bidirectional effect Effects 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 210000000234 capsid Anatomy 0.000 description 1
- 206010008118 cerebral infarction Diseases 0.000 description 1
- 238000002038 chemiluminescence detection Methods 0.000 description 1
- 210000004691 chief cell of stomach Anatomy 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 239000000356 contaminant Substances 0.000 description 1
- 239000012228 culture supernatant Substances 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 238000011010 flushing procedure Methods 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 238000010166 immunofluorescence Methods 0.000 description 1
- 230000005847 immunogenicity Effects 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 210000004962 mammalian cell Anatomy 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 238000005374 membrane filtration Methods 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 230000000116 mitigating effect Effects 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 208000015122 neurodegenerative disease Diseases 0.000 description 1
- 229940055695 pancreatin Drugs 0.000 description 1
- 229920002866 paraformaldehyde Polymers 0.000 description 1
- 235000011837 pasties Nutrition 0.000 description 1
- 239000013600 plasmid vector Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 229920002981 polyvinylidene fluoride Polymers 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 238000000751 protein extraction Methods 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 238000004153 renaturation Methods 0.000 description 1
- 238000009256 replacement therapy Methods 0.000 description 1
- 239000003161 ribonuclease inhibitor Substances 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 235000020183 skimmed milk Nutrition 0.000 description 1
- 239000004055 small Interfering RNA Substances 0.000 description 1
- 238000011476 stem cell transplantation Methods 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000009897 systematic effect Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 238000010361 transduction Methods 0.000 description 1
- 230000026683 transduction Effects 0.000 description 1
- 238000003151 transfection method Methods 0.000 description 1
- 238000010023 transfer printing Methods 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
- 238000005199 ultracentrifugation Methods 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Images
Landscapes
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Description
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2007101187265A CN101117625B (zh) | 2007-07-12 | 2007-07-12 | 诱导间充质干细胞和脂肪干细胞分化为神经元的方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2007101187265A CN101117625B (zh) | 2007-07-12 | 2007-07-12 | 诱导间充质干细胞和脂肪干细胞分化为神经元的方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101117625A true CN101117625A (zh) | 2008-02-06 |
CN101117625B CN101117625B (zh) | 2010-08-04 |
Family
ID=39053885
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2007101187265A Expired - Fee Related CN101117625B (zh) | 2007-07-12 | 2007-07-12 | 诱导间充质干细胞和脂肪干细胞分化为神经元的方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101117625B (zh) |
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104004713A (zh) * | 2014-05-14 | 2014-08-27 | 安沂华 | 脐带间充质干细胞诱导培养为神经细胞的方法 |
CN104285147A (zh) * | 2012-02-29 | 2015-01-14 | Mjn美国控股有限责任公司 | 使用脂肪组织衍生的干细胞的神经发生筛选方法和系统 |
CN104789531A (zh) * | 2015-03-27 | 2015-07-22 | 安沂华 | 一种将脐带间充质干细胞诱导分化成多巴胺能神经元的方法 |
US9428730B2 (en) | 2012-02-29 | 2016-08-30 | Mead Johnson Nutrition Company | Coatings and culture media for promoting neurogenesis in adipose tissue derived stem cells |
CN107034185A (zh) * | 2017-05-08 | 2017-08-11 | 中国人民解放军第二军医大学 | 一种裸鼹鼠骨髓间充质干细胞的原代分离培养方法 |
CN109136227A (zh) * | 2018-10-10 | 2019-01-04 | 新乡医学院 | 长链非编码rna-hoxa-as2在骨组织损伤修复中的应用 |
CN109837241A (zh) * | 2019-03-20 | 2019-06-04 | 济南赛尔生物科技股份有限公司 | 脂肪干细胞的分离与培养方法 |
CN111304167A (zh) * | 2018-12-12 | 2020-06-19 | 上海泉眼生物科技有限公司 | 人源脂肪干细胞来源的神经元前体细胞及其制备方法和应用 |
CN111621525A (zh) * | 2020-06-18 | 2020-09-04 | 山东如戴生物科技有限公司 | Stx1b基因在促进人脂肪间充质干细胞生长和分化中的用途 |
CN115141804A (zh) * | 2022-09-05 | 2022-10-04 | 南京鼓楼医院 | 一种基于脂肪外泌体的神经元转染方法及其应用 |
-
2007
- 2007-07-12 CN CN2007101187265A patent/CN101117625B/zh not_active Expired - Fee Related
Cited By (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104285147B (zh) * | 2012-02-29 | 2017-10-27 | Mjn 美国控股有限责任公司 | 使用脂肪组织衍生的干细胞的神经发生筛选方法和系统 |
CN104285147A (zh) * | 2012-02-29 | 2015-01-14 | Mjn美国控股有限责任公司 | 使用脂肪组织衍生的干细胞的神经发生筛选方法和系统 |
US9428730B2 (en) | 2012-02-29 | 2016-08-30 | Mead Johnson Nutrition Company | Coatings and culture media for promoting neurogenesis in adipose tissue derived stem cells |
CN104004713A (zh) * | 2014-05-14 | 2014-08-27 | 安沂华 | 脐带间充质干细胞诱导培养为神经细胞的方法 |
CN104789531A (zh) * | 2015-03-27 | 2015-07-22 | 安沂华 | 一种将脐带间充质干细胞诱导分化成多巴胺能神经元的方法 |
CN104789531B (zh) * | 2015-03-27 | 2017-10-27 | 安沂华 | 一种将脐带间充质干细胞诱导分化成多巴胺能神经元的方法 |
CN107034185B (zh) * | 2017-05-08 | 2021-05-07 | 中国人民解放军第二军医大学 | 一种裸鼹鼠骨髓间充质干细胞的原代分离培养方法 |
CN107034185A (zh) * | 2017-05-08 | 2017-08-11 | 中国人民解放军第二军医大学 | 一种裸鼹鼠骨髓间充质干细胞的原代分离培养方法 |
CN109136227A (zh) * | 2018-10-10 | 2019-01-04 | 新乡医学院 | 长链非编码rna-hoxa-as2在骨组织损伤修复中的应用 |
CN109136227B (zh) * | 2018-10-10 | 2021-11-12 | 新乡医学院 | 长链非编码rna-hoxa-as2在骨组织损伤修复中的应用 |
CN111304167A (zh) * | 2018-12-12 | 2020-06-19 | 上海泉眼生物科技有限公司 | 人源脂肪干细胞来源的神经元前体细胞及其制备方法和应用 |
CN111304167B (zh) * | 2018-12-12 | 2024-03-26 | 上海泉眼生物科技有限公司 | 人源脂肪干细胞来源的神经元前体细胞及其制备方法和应用 |
CN109837241A (zh) * | 2019-03-20 | 2019-06-04 | 济南赛尔生物科技股份有限公司 | 脂肪干细胞的分离与培养方法 |
CN109837241B (zh) * | 2019-03-20 | 2022-05-17 | 济南赛尔生物科技股份有限公司 | 脂肪干细胞的分离与培养方法 |
CN111621525A (zh) * | 2020-06-18 | 2020-09-04 | 山东如戴生物科技有限公司 | Stx1b基因在促进人脂肪间充质干细胞生长和分化中的用途 |
CN111621525B (zh) * | 2020-06-18 | 2021-04-23 | 中赛干细胞基因工程有限公司 | Stx1b基因在促进人脂肪间充质干细胞生长和分化中的用途 |
CN115141804A (zh) * | 2022-09-05 | 2022-10-04 | 南京鼓楼医院 | 一种基于脂肪外泌体的神经元转染方法及其应用 |
CN115141804B (zh) * | 2022-09-05 | 2023-01-20 | 南京鼓楼医院 | 一种基于脂肪外泌体的神经元转染方法及其应用 |
Also Published As
Publication number | Publication date |
---|---|
CN101117625B (zh) | 2010-08-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101117625B (zh) | 诱导间充质干细胞和脂肪干细胞分化为神经元的方法 | |
CN101591653A (zh) | 低表达cyp7a1的肝细胞及其构建方法 | |
CN102382801B (zh) | 蛋白去乙酰化酶sirt1在促进间充质干细胞增殖与延缓衰老中的应用 | |
CN104531700B (zh) | 抑制小鼠MACF1基因表达的shRNA序列及其应用 | |
AU2021307014B2 (en) | miR-30a-5p and application thereof in promoting nerve regeneration and repairing peripheral nerve injury | |
CN112641938A (zh) | 一种dna重组干细胞载体新冠疫苗 | |
CN107523569A (zh) | Pdcd1基因的用途及其相关药物 | |
US9334502B2 (en) | Use of human NLK gene and associated drugs thereof | |
CN105039342A (zh) | 能抑制MAT2A基因表达的siRNA及其应用 | |
CN110218726A (zh) | 一种用于抑制大鼠Cacna1c基因表达的shRNA及其用途 | |
CN101418285A (zh) | 诱导肝卵圆细胞向胆管细胞分化的方法及其专用培养基 | |
CN108465108B (zh) | 一种预防或治疗脑胶质瘤的特异性基因靶点 | |
CN114672460B (zh) | 一种靶向cd44的异质型cic细胞模型的制备方法及应用 | |
CN103305596B (zh) | 人rnf138基因的用途及其相关药物 | |
US9434949B2 (en) | Uses of the human ZFX gene and drugs associated with same | |
CN108949974B (zh) | E3泛素连接酶asb3在制备肝癌治疗药物中的应用 | |
CN113637633A (zh) | 一种促进间充质干细胞向成骨细胞分化的方法 | |
CN112618708A (zh) | 一种hACE2敲除的RNA干扰干细胞载体新冠疫苗 | |
CN112646780A (zh) | 一种hACE2敲除的新冠病毒基因沉默干细胞 | |
CN112553164A (zh) | 一种治疗covid-19的基因改造干细胞 | |
CN112779294A (zh) | 一种人造新冠病毒吞噬细胞的方法 | |
CN102311940A (zh) | 诱导干细胞向胰岛样细胞分化的方法 | |
CN112553163A (zh) | 一种hACE2敲入的新冠病毒RNA干扰干细胞 | |
Luo et al. | AlphaB-crystallin promotes porcine circovirus type 2 replication in a cell proliferation-dependent manner | |
CN113832109B (zh) | 一种骨髓间充质干细胞外泌体及其制备方法和应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
EE01 | Entry into force of recordation of patent licensing contract |
Application publication date: 20080206 Assignee: SOUTH CHINA CENTER FOR STEM CELL BIOLOGY AND REGENERATIVE MEDICINE OF ACADEMY OF MILITARY MEDICAL SCIENCES Assignor: INSTITUE OF TRANSFUSION MEDICINE, ACADEMY OF MILITARY MEDICAL SCIENCES, PEOPLE'S LIBRATION ARMY OF CHINA Contract record no.: 2015990000123 Denomination of invention: Method for evoking differentiation of mesenchyma stem cell and fat stem cell into neurons and special culture medium thereof Granted publication date: 20100804 License type: Exclusive License Record date: 20150324 |
|
LICC | Enforcement, change and cancellation of record of contracts on the licence for exploitation of a patent or utility model | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20100804 |
|
CF01 | Termination of patent right due to non-payment of annual fee |